CDH17 and Huntington disease: Cellular abnormalities including mitochondrial deficits, low levels of BDNF, altered cadherin and TGF-β signaling, impaired neural rosette formation and increased susceptibility to growth factor withdrawal were rescued in corrected isogenic HD lines (An et al., 2014; Xu et al., 2017).